24 August 2016 - CADTH is in favour of the reimbursement of Gilead's new dual combination product for HIV-1 infection. ...
24 August 2016 - The recommendation comes with conditions. ...
5 February 2016 - CADTH has received notice of pending submissions from Theratechnologies for Egrifta (tesamorelin acetate) for lipodystrophy in HIV-infected ...
27 August 2015 - CADTH has received notice of a pending submission from GIlead for elvitegravir with cobicistat and emtricitabine and ...